CASEY OVERTURF: Open Payments
NPI 1114305935 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 36 payments from 14 companies in 2025. Trend: 2023 $1,447 · 2024 $1,633 · 2025 $931
Food & beverage: $831Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $375 |
| PFIZER INC. | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Incyte Corporation | 4 | $65 |
| Organon LLC | 2 | $54 |
| Galderma Laboratories, L.P. | 2 | $54 |
| UCB, Inc. | 1 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
| Lilly USA, LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $27 |
Products named: TREMFYA, DUPIXENT, CIBINQO, OPZELURA, NEMLUVIO, Bimzelx, EBGLYSS, YCANTH.
Industry payments across FL — which companies pay providers there.
